» Articles » PMID: 15713631

Maspin Mediates Increased Tumor Cell Apoptosis Upon Induction of the Mitochondrial Permeability Transition

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2005 Feb 17
PMID 15713631
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Maspin is a unique serpin with the ability to suppress certain types of malignant tumors. It is one of the few p53-targeted genes involved in tumor invasion and metastasis. With this in mind, we attempted to study the molecular mechanism behind this tumor suppression. Maspin-expressing mammary tumors are more susceptible to apoptosis in both implanted mammary tumors in vivo, a three-dimensional spheroid culture system, as well as in monolayer cell culture under lowered growth factors. Subcellular fractionation shows that a fraction of maspin (in both TM40D-Mp and mutant maspinDeltaN cells) translocates to the mitochondria. This translocation of maspin to the mitochondria is linked to the opening of the permeability transition pore, which in turn causes the loss of transmembrane potential, thus initiating apoptotic degradation. This translocation is absent in the other mutant, maspinDeltaRSL. It fails to cause any loss of membrane potential and also shows decreased caspase 3 levels, proving that translocation to the mitochondria is a key event for this increase in apoptosis by maspin. Suppression of maspin overexpression by RNA interference desensitizes cells to apoptosis. Our data indicate that maspin inhibits tumor progression through the mitochondrial apoptosis pathway. These findings will be useful for maspin-based therapeutic interventions against breast cancer.

Citing Articles

Opposing Functions of Maspin Are Regulated by Its Subcellular Localization in Lung Squamous Cell Carcinoma Cells.

Matsushige T, Sakabe T, Mochida H, Umekita Y Cancers (Basel). 2024; 16(17).

PMID: 39272867 PMC: 11394258. DOI: 10.3390/cancers16173009.


Mesenchymal stem cell suppresses the efficacy of CAR-T toward killing lymphoma cells by modulating the microenvironment through stanniocalcin-1.

Zhang R, Liu Q, Zhou S, He H, Zhao M, Ma W Elife. 2023; 12.

PMID: 36779699 PMC: 10019890. DOI: 10.7554/eLife.82934.


Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects.

Tang S, Ling Z, Jiang J, Gu X, Leng Y, Wei C Front Oncol. 2022; 12:1037794.

PMID: 36523976 PMC: 9745138. DOI: 10.3389/fonc.2022.1037794.


Investigation of the Subcellular Localization-Dependent Anti- or Pro-Tumor Functions of Maspin in Human Lung Adenocarcinoma Cell Line.

Matsushige T, Sakabe T, Umekita Y Yonago Acta Med. 2022; 65(1):44-52.

PMID: 35221759 PMC: 8857674. DOI: 10.33160/yam.2022.02.006.


Homologous recombination proficiency in ovarian and breast cancer patients.

Creeden J, Nanavaty N, Einloth K, Gillman C, Stanbery L, Hamouda D BMC Cancer. 2021; 21(1):1154.

PMID: 34711195 PMC: 8555001. DOI: 10.1186/s12885-021-08863-9.


References
1.
Li L, Luo X, Wang X . Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 2001; 412(6842):95-9. DOI: 10.1038/35083620. View

2.
Shi H, Zhang W, Liang R, Abraham S, Kittrell F, Medina D . Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res. 2001; 61(18):6945-51. View

3.
Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R . A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell. 2001; 8(3):613-21. DOI: 10.1016/s1097-2765(01)00341-0. View

4.
Reers M, Smiley S, Chen A, Lin M, Chen L . Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol. 1995; 260:406-17. DOI: 10.1016/0076-6879(95)60154-6. View

5.
Sager R, Sheng S, Pemberton P, Hendrix M . Maspin: a tumor suppressing serpin. Curr Top Microbiol Immunol. 1996; 213 ( Pt 1):51-64. DOI: 10.1007/978-3-642-61107-0_4. View